New Data on HIV Prevention
In 2006, Gilead scientists began work on a potential long-acting HIV medication. After more than a decade of preclinical development and clinical trials, we’ve now announced topline results from a study investigating its use for HIV prevention.
Our Purpose
We’ve been taking on the world’s biggest health challenges for more than 35 years. We continue to set and achieve ambitious goals to create a healthier world for all people.
Our MissionRecent Stories
Join Our Team
We're Hiring